We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

Back to rankings

98 hedge funds and large institutions have $228M invested in Albany Molecular Research Inc in 2013 Q2 according to their latest regulatory filings, with 98 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

49% less call options, than puts

Call options by funds: $317K | Put options by funds: $627K

Holders
98
Holders Change
+98
Holders Change %
–
% of All Funds
3.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
98
Increased
–
Reduced
–
Closed
–
Calls
$317K
Puts
$627K
Net Calls
-$310K
Net Calls Change
-$310K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Manulife (Manufacturers Life Insurance)
76
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$199K +$182K +16,843 New
Deutsche Bank
77
Deutsche Bank
Germany
$186K +$170K +15,717 New
SCA
78
SAC Capital Advisors
Connecticut
$176K +$160K +14,790 New
Group One Trading
79
Group One Trading
Illinois
$165K +$151K +13,917 New
AllianceBernstein
80
AllianceBernstein
Tennessee
$154K +$141K +12,985 New
Citigroup
81
Citigroup
New York
$145K +$133K +12,239 New
US Bancorp
82
US Bancorp
Minnesota
$141K +$129K +11,873 New
N
83
Natixis
France
$139K +$127K +11,700 New
NFA
84
Nationwide Fund Advisors
Ohio
$137K +$125K +11,539 New
Bank of Montreal
85
Bank of Montreal
Ontario, Canada
$135K +$123K +11,381 New
Principal Financial Group
86
Principal Financial Group
Iowa
$127K +$116K +10,706 New
Two Sigma Investments
87
Two Sigma Investments
New York
$119K +$108K +10,003 New
CCMH
88
Cornerstone Capital Management Holdings
New York
$112K +$102K +9,400 New
BJ
89
BlackRock Japan
Japan
$81K +$73.7K +6,800 New
TRCT
90
Tower Research Capital (TRC)
New York
$70K +$63.9K +5,899 New
First Manhattan
91
First Manhattan
New York
$37K +$32.5K +3,000 New
SGAM
92
Smith Group Asset Management
Texas
$25K +$22.7K +2,098 New
Ameriprise
93
Ameriprise
Minnesota
$22K +$20K +1,850 New
Wells Fargo
94
Wells Fargo
California
$18K +$16.1K +1,484 New
MFS
95
MSI Financial Services
Massachusetts
$12K +$10.8K +1,000 New
Barclays
96
Barclays
United Kingdom
$7K +$6.65K +614 New
BlackRock
97
BlackRock
New York
$7K +$6.66K +615 New
GC
98
Globeflex Capital
California
$2K +$2.39K +221 New
1 2 3
4

AMRI Hedge Fund Activity: Q2 2013 in Review

98 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q2 2013, worth a combined $228M.

Buyers outnumbered sellers: 98 funds opened new AMRI positions and 0 closed out — a net gain of 98 holders — while 0 added to existing stakes and 0 trimmed.

  • 98 institutional investors held Albany Molecular Research Inc (AMRI) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $228M of Albany Molecular Research Inc stock for Q2 2013.
  • 98 funds opened new Albany Molecular Research Inc positions in Q2 2013 and 0 closed out, a net change of +98 holders.

Based on aggregated 13F filings for Q2 2013.